The Secret “Zombie Cell” Killers: Niche Senolytic Drugs Fighting Aging’s Clock
A Mayo Clinic-led Phase 2 trial published July 2024 found dasatinib plus quercetin modestly increased wrist bone density in older women with high senescent-cell burden. Unity Biotechnology’s foselutoclax improved vision in diabetic macular edema patients after a single injection. About 20 senolytic clinical trials are underway worldwide, with Alzheimer’s disease results expected in 2025.